RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
46 hedge funds and large institutions have $22.4M invested in Regulus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
53% less call options, than puts
Call options by funds: $19K | Put options by funds: $40K
Holders
46
Holding in Top 10
–
Calls
$19K
Puts
$40K
Top Buyers
| 1 | +$2.62M | |
| 2 | +$2.17M | |
| 3 | +$463K | |
| 4 |
Goldman Sachs
New York
|
+$237K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$164K |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$539K | |
| 3 | -$333K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$203K |
| 5 |
Renaissance Technologies
New York
|
-$195K |